Bruker Molecular Diagnostics at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Bruker Molecular Diagnostics brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 2401. Its sessions centre on automated infectious disease testing, from a sample-to-result measles PCR assay to bloodstream infection workup. Another covers rapid identification and phenotypic minimum inhibitory concentration results straight from positive blood cultures.
| Organization | AMP 2026 Attendance |
|---|---|
Bruker Molecular Diagnostics Bothell, WA | |
Reagents for oligonucleotide labeling, including fluorescence-based probes and modified nucleobases for nucleic acid labeling. | Booth Exhibiting at Booth 2401 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 11:00am–11:50am Analytical Evaluation of the ELITe® DSQ Alert® Measles Real-Time PCR Assay on the ELITe BeGenius® and InGenius® Sample-To-Result Automated Systems Measles RT-PCR on automated sample-to-result systems, validated to tell wild-type virus from vaccine strain by melt curve. Workshop Fri, Nov 13 9:30am–10:00am Closing the Bloodstream Infection Diagnostic Gap: Rapid Identification and Phenotypic MIC Determination from Positive Blood Cultures Faster species identification and phenotypic susceptibility results straight from positive blood cultures in suspected sepsis. |
Instantly find 20 buyers from Bruker Molecular Diagnostics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction